- Home
- CPRX vs RLJ Comparison
CPRX vs RLJ Comparison
Compare CPRX & RLJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPRX
- RLJ
- Stock Information
- Founded
- CPRX 2002
- RLJ 2011
- Country
- CPRX United States
- RLJ United States
- Employees
- CPRX N/A
- RLJ N/A
- Industry
- CPRX Biotechnology: Pharmaceutical Preparations
- RLJ Real Estate Investment Trusts
- Sector
- CPRX Health Care
- RLJ Real Estate
- Exchange
- CPRX Nasdaq
- RLJ Nasdaq
- Market Cap
- CPRX 2.4B
- RLJ 1.4B
- IPO Year
- CPRX 2006
- RLJ 2011
- Fundamental
- Price
- CPRX $21.15
- RLJ $9.22
- Analyst Decision
- CPRX Strong Buy
- RLJ Hold
- Analyst Count
- CPRX 6
- RLJ 7
- Target Price
- CPRX $29.50
- RLJ $11.67
- AVG Volume (30 Days)
- CPRX 936.6K
- RLJ 1.6M
- Earning Date
- CPRX 11-06-2024
- RLJ 11-06-2024
- Dividend Yield
- CPRX N/A
- RLJ 4.91%
- EPS Growth
- CPRX N/A
- RLJ N/A
- EPS
- CPRX 0.58
- RLJ 0.26
- Revenue
- CPRX $434,475,000.00
- RLJ $1,348,127,000.00
- Revenue This Year
- CPRX $21.33
- RLJ N/A
- Revenue Next Year
- CPRX $17.29
- RLJ $2.54
- P/E Ratio
- CPRX $36.45
- RLJ $35.77
- Revenue Growth
- CPRX 43.42
- RLJ 4.32
- 52 Week Low
- CPRX $11.89
- RLJ $8.79
- 52 Week High
- CPRX $21.85
- RLJ $12.39
- Technical
- Relative Strength Index (RSI)
- CPRX 64.52
- RLJ 47.48
- Support Level
- CPRX $19.54
- RLJ $9.04
- Resistance Level
- CPRX $21.85
- RLJ $9.33
- Average True Range (ATR)
- CPRX 0.49
- RLJ 0.20
- MACD
- CPRX 0.14
- RLJ -0.02
- Stochastic Oscillator
- CPRX 82.40
- RLJ 45.00
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.
About RLJ RLJ Lodging Trust of Beneficial Interest $0.01 par value
RLJ Lodging Trust is a real estate investment trust that acquires focused-service and compact full-service hotels. Its portfolio consists of hotels in various states across the United States and the District of Columbia. Its hotels are under the Marriott, Hilton, and Hyatt brand names. These hotels are concentrated in urban areas, dense suburban markets, and business districts within metropolitan areas. Its revenue streams include hotel operations revenue, which is composed of the sale of rooms, food, and beverages, and other property revenue. The company derives the substantial majority of its revenue from the operation of hotels.